A New Approach of Mitigating CYP3A4 Induction Led to the Discovery of Potent Hepatitis B Virus (HBV) Capsid Inhibitor with Optimal ADMET Profiles.

Publication

Citation
Lin X, Shi H, Zhang W, Qiu Z, Zhou Z, Dey F, Zhong S, Qiu H, Xie J, Zhou X, Yang G, Tang G, Shen HC, Zhu W.: A New Approach of Mitigating CYP3A4 Induction Led to the Discovery of Potent Hepatitis B Virus (HBV) Capsid Inhibitor with Optimal ADMET Profiles. J Med Chem, Volume 62 (22), 2019
Authors
Dey F, Lin X, Qiu H, Qiu Z, Shen HC, Shi H, Tang G, Xie J, Yang G, Zhang W, Zhong S, Zhou X, Zhou Z, Zhu W.
Journal
J Med Chem
Year
2019
PubMed
31689116
Machine-readable
REST APIRDF
Palacky University Olomouc

Palacky University Olomouc

Faculty of Science

Department of Physical Chemistry

tř. 17. listopadu 1192/12

771 46 Olomouc

Czech Republic

How to cite?

Juračka J., Šrejber M., Melíková M., Bazgier V., Berka K.: MolMeDB: Molecules on Membranes Database. Database, Volume 2019, 2019, baz078, https://doi.org/10.1093/database/baz078

Follow us

FacebookGithub

Financial Support

  • MolMeDB interoperability with UniProt and SwissLipids – MEYS Czech-Swiss project ELIXIR-IMPACT 8K0208 (2026–2028)
ELIXIRGAČRUP Olomouc